FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates to novel derivatives of 2-pyrrolidone of the formula (I): wherein Q means -CH2-, -O-; B means -CH2-, -(CH2)2-, -(CH2)3-, -(CH2)4-, -(CH2)5-, -CH=CH-, -CH2-CH=CH-, -CH=CH-CH2-, -CH2-CH=CH-CH2 under condition that if B means -CH=CH-, -CH=CH-CH2- then Q means -CH2-; X means -O-, -S-, -SO- or -SO2- or a simple bond under condition that if X meana simple bond then Q means oxygen atom; J means -(CRbRc)n- wherein n means a whole number from 1 to 4; both Rb and Rc mean hydrogen atom, or both Rb and Rc mean (C1-C4)-alkyl and one of them means hydrogen atom (H), or Rb and Rc in common with carbon atom to which they are bound form (C2-C5)-polymethylene group or -CH2-CH=CH-; A means -CH2-CH2-, -CH=CH- or -C≡C-; Z means -C(O)OR' wherein R' means H, (C1-C6)-alkyl; n means 1, 2, 3 or 4; R1 means -(CH2)pR7 wherein R7 means (C1-C)-alkyl, (C3-C8)-cycloalkyl, furanyl substituted with trifluoromethyl, phenyl or phenyl-Y-phenyl wherein Y means oxygen atom (O), a simple chemical bond and phenyl is optionally substituted with 1, 2 or three substitutes chosen independently from group comprising (C1-C6)-alkyl, (C1-C6)-alkoxy-group, halogen atom, halogen-(C1-C6)-alkyl; p means 0, 1, 2, 3, 4, 5; R2 means H, (C1-C6)-alkyl; R3, R4, R5 and R6 mean H, or their pharmaceutically acceptable salts or solvates, individual isomers or racemic or nonracemic mixture of isomers. Compounds of the formula (I) elicit competitive affinity in binding EP2, EP3 and EP4 that allows their using as components of pharmaceutical composition.
EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions.
11 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PROSTAGLANDIN ANALOGS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION POSSESSING SELECTIVE AGONISTIC ACTIVITY WITH RESPECT TO EP-RECEPTOR | 2002 |
|
RU2288913C2 |
DERIVATIVES OF 2-PIPERIDONE AS PROSTAGLANDIN AGONISTS | 2004 |
|
RU2311409C2 |
SUBSTITUTED GAMMA-LACTAMS AS THERAPEUTIC AGENTS | 2006 |
|
RU2412933C2 |
DERIVATIVES OF PYRROLIDONE AS MONOAMINE OXIDASE B (MAO B) AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2003 |
|
RU2323209C2 |
DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
INTERMEDIATE PRODUCTS FOR PRODUCING NEUTRAL ENDOPEPTIDASE INHIBITORS AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2564024C2 |
METHOD OF OBTAINING BENZIMIDAZOLECARBAMATES (VERSIONS) | 0 |
|
SU1169532A3 |
DERIVATIVES OF NICOTINE- OR ISONICOTINE-BENZOTHIAZOLE AND MEDICINAL AGENT | 2002 |
|
RU2294933C2 |
METHOD FOR PRODUCING [1,2,3,4]-TETRAZINO-[5,6-e]-[1,2,3,4]-TETRAZINO-1,3,6,8-TETRAOXIDE | 2015 |
|
RU2593993C1 |
TOCOPHEROLS, TOCOTRIENOLS AND OTHER DERIVATIVES OF CHROMAN AND BY-SIDE CHAINS AND METHODS FOR TREATMENT WITH THEIR USING | 1999 |
|
RU2232758C2 |
Authors
Dates
2007-03-27—Published
2002-07-11—Filed